SSY Group Ltd

1
HKSE:02005 (Hong Kong)  
HK$ 4.88 (+4.27%) Jun 6
10.88
P/B:
2.06
Market Cap:
HK$ 14.49B ($ 1.86B)
Enterprise V:
HK$ 15.65B ($ 2.00B)
Volume:
886.00K
Avg Vol (2M):
2.63M
Also Trade In:
Volume:
886.00K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for SSY Group Ltd ( ) from 2005 to Jun 06 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. SSY Group stock (HKSE:02005) PE ratio as of Jun 06 2024 is 10.88. More Details

SSY Group Ltd (HKSE:02005) PE Ratio (TTM) Chart

To

SSY Group Ltd (HKSE:02005) PE Ratio (TTM) Historical Data

Total 1221
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
SSY Group PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-06 11.0 2024-04-02 11.3
2024-06-06 11.0 2024-03-28 11.7
2024-06-05 10.6 2024-03-27 10.3
2024-06-04 10.7 2024-03-26 10.1
2024-06-03 10.5 2024-03-25 10.2
2024-05-31 10.6 2024-03-22 10.5
2024-05-30 10.7 2024-03-21 10.6
2024-05-29 10.6 2024-03-20 10.5
2024-05-28 10.7 2024-03-19 10.5
2024-05-27 10.8 2024-03-18 10.5
2024-05-24 10.4 2024-03-15 10.6
2024-05-23 10.7 2024-03-14 10.8
2024-05-22 10.7 2024-03-13 10.6
2024-05-21 10.6 2024-03-12 10.5
2024-05-20 10.9 2024-03-11 10.4
2024-05-17 10.9 2024-03-08 10.4
2024-05-16 11.0 2024-03-07 10.5
2024-05-14 11.1 2024-03-06 10.4
2024-05-13 11.3 2024-03-05 10.4
2024-05-10 11.1 2024-03-04 10.6
2024-05-09 10.8 2024-03-01 10.1
2024-05-08 10.8 2024-02-29 9.9
2024-05-07 11.0 2024-02-28 10.1
2024-05-06 10.9 2024-02-27 10.0
2024-05-03 10.8 2024-02-26 10.0
2024-05-02 10.6 2024-02-23 10.1
2024-04-30 10.8 2024-02-22 9.8
2024-04-29 10.8 2024-02-21 9.8
2024-04-26 10.8 2024-02-20 9.8
2024-04-25 10.7 2024-02-19 9.5
2024-04-24 10.7 2024-02-16 9.4
2024-04-23 10.6 2024-02-15 9.1
2024-04-22 10.7 2024-02-14 9.1
2024-04-19 10.6 2024-02-09 9.2
2024-04-18 10.6 2024-02-08 9.4
2024-04-17 10.9 2024-02-07 9.4
2024-04-16 10.4 2024-02-06 9.5
2024-04-15 10.8 2024-02-05 9.1
2024-04-12 11.1 2024-02-02 9.3
2024-04-11 11.2 2024-02-01 9.6
2024-04-10 11.2 2024-01-31 9.6
2024-04-09 11.2 2024-01-30 9.7
2024-04-08 10.9 2024-01-29 10.2
2024-04-05 10.9 2024-01-26 10.1
2024-04-03 11.1 2024-01-25 10.2

SSY Group Ltd (HKSE:02005) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
SSY Group Ltd is engaged in the research, development, manufacturing and selling of a wide range of pharmaceutical products, which includes finished medicines of mainly intravenous infusion solution and ampoule injection to hospitals and distributors, bulk pharmaceuticals and medical materials. The company has two reportable segments including intravenous infusion solution and others and medical materials. The company derives a vast majority of its revenue principally from the Intravenous infusion solution and others. Revenue generation is driven mostly by its sales of pharmaceutical products, followed by medical materials.